Melissa Carbon, MA, CCRP assumes Director position, opens California HCRAmerica office

PRINCETON, N.J. & MUNICH, Germany--(BUSINESS WIRE)-- The Harrison Clinical Research Group GmbH, a leading full-service, scientifically and medically driven clinical research organization with offices worldwide, is pleased to announce that Melissa Carbon has joined the company as Director, Clinical Operations of HCRAmerica, our USA affiliate, based in its West Coast, California office. Ms. Carbon is responsible for providing strategic operational leadership and overseeing the management of North American and International Phase I-IV clinical trials. Ms. Carbon excels at building effective sponsor-CRO relationships and is a highly accomplished International clinical trials specialist having successfully managed more than 100 clinical trials for CNS, CV, Oncology, GI, ID and other therapeutic indications over the past 14 years.

Prior to joining HCRAmerica, Ms. Carbon held the position of Director of Clinical Operations for Advanced Biomedical Research, Inc. (ABR). Ms. Carbon worked at ABR for over 10 years under the leadership of founder, Dr. Michael S. Willett. Melissa played a key role in managing pivotal Phase III CNS and oncology clinical trials in adult and pediatric patient populations among her many accomplishments at ABR. Ms. Carbon also previously helped to start up the San Diego office of Scirex (now part of Premier Research). Ms. Carbon received her undergraduate degree from San Diego State University and her Master of Psychology degree from Chapman University.

Dr. Francisco Harrison, founder of HCR commented, “I am delighted to welcome Melissa to our company. She brings talent, experience and boundless energy and enthusiasm to our company. Her experience in working with US, European and Japanese clients and Investigators from around the world will be a tremendous asset to us.” Dr. Michael Willett added that, “As we continue to grow our American presence, I am especially pleased to be reunited with Melissa here at HCRAmerica. Melissa has a unique passion for clinical trials and brings her special talent for building and motivating high performance project teams to HCR. Her customer-centric approach creates durable relationships with clients who quickly come to appreciate they can rely on Melissa and her team to deliver high quality results on-time and within budget.”

About HCRAmerica and Harrison Clinical Research Group GmbH

HCRAmerica is the US affiliate of Harrison Clinical Research Group GmbH, a full-service Phase I-IV global CRO with a staff of over 400 clinical research professionals and offices in 12 countries throughout the USA, Europe and Russia. HCR also has well established partners in the USA, Canada, Scandinavia, South America, South Africa, Australia, India and Japan. HCR has a 22-year track record of service excellence in providing timely and reliable performance of clinical trials. HCR has the understanding and strategic network to offer a full range of clinical research activities throughout the USA, Europe and worldwide. Our team is proud of its quality and is ISO 9001 certified for the performance of Phase I, II, III and IV clinical trials.

Harrison Clinical Research ■ Outsourcing Dedication ■ www.harrisonclinical.com

Harrison Clinical Research Group GmbH

Francisco Harrison, MD, +49 89-126680-0

Chairman

Albrechtstrasse 43, 80636 München, Germany

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

or

HCRAmerica, LLC

Michael S. Willett, PharmD, +1 609-987-1700

President & Managing Director

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

or

HCRAmerica, LLC

Melissa R. Carbon, MA, CCRP, +1 951-272-2084

Director Clinical Operations

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Source: Harrison Clinical Research Group GmbH